Michael Mauro, MD

Articles

Michael Mauro Discusses Therapy-Free CML Remission

December 31, 2015

Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission. 

Dr. Mauro Discusses Drug Adherence Among CML Patients

February 25, 2015

Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Leukemia Service at Memorial Sloan Kettering Cancer Center, explains why some patients with CML don't adhere to their medication.